A longitudinal study of cannabis use increasing the use of asthma medication in young Norwegian adults

• Research article
• Open Access
• Open Peer Review

BMC Pulmonary Medicine

• Jørgen G. BramnessEmail author and
• Tilmann von Soest

BMC Pulmonary Medicine201919:52

https://doi.org/10.1186/s12890-019-0814-x

Open Peer Review reports

Abstract

Background

A small number of studies have shown that the use of cannabis increases the risk of bronchial asthma. There is, however, a paucity of longitudinal studies which are able to control for known risk factors of bronchial asthma.

Comparison of therapeutic effects of inhaled corticosteroids on three subtypes of cough variant asthma as classified by the impulse oscillometry system

• Research
• Open Access
• 
  

Respiratory Research

• Hiroyuki Sugawara,
• Atsushi SaitoEmail authorView ORCID ID profile,
• Saori Yokoyama,
• Kazunori Tsunematsu and
• Hiroki Takahashi

Respiratory Research201920:41

https://doi.org/10.1186/s12931-019-1005-2

Abstract

Background

Cough variant asthma (CVA) is one of the most common causes of chronic persistent cough, and early treatment with inhaled corticosteroids (ICSs) is recommended to attenuate the inflammation and remodeling.

Tumor necrosis factor-alpha and Fas/Fas ligand signaling pathways in chronic spontaneous urticaria

Allergy, Asthma & Clinical Immunology
•   Research
• Open Access
• 
  

• R. Grzanka,
• A. Damasiewicz-Bodzek and
• A. Kasperska-ZajacEmail authorView ORCID ID profile

Allergy, Asthma & Clinical Immunology201915:15

Abstract

Background

There is increasing evidence pointing to the important role of tumor necrosis factor-alpha (TNF-α), a key inflammatory and apoptotic mediator in urticarial inflammation. However, the role of the TNF-α system and Fas/Fas ligand (FasL) in the apoptosis-inducing pathways in chronic spontaneous urticaria (CSU), remain unclear.

Bronchoalveolar lavage cell profiles and proteins concentrations can be used to phenotype extrinsic allergic alveolitis patients

• Original research article
• Open Access

Martina Sterclova

,

Magdalena Smetakova,

Ludek Stehlik,

Jelena Skibova and

Martina Vasakova

Multidisciplinary Respiratory Medicine201914:13

Abstract

Background

Extrinsic allergic alveolitis (EAA) patients form heterogenous group with different clinical manifestation and different prognosis. We aimed to determine how to phenotype distinct EAA subgroups. Predictive role of the bronchoalveolar lavage fluid (BALF) IL-4Rα concentration at the time of diagnosis with regard to the clinical behavior in EAA patients was studied.

Indirect comparison of intravenous vs. subcutaneous C1-inhibitor placebo-controlled trials for routine prevention of hereditary angioedema attacks

Allergy, Asthma & Clinical Immunology
• Research
• Open Access

• Jonathan A. BernsteinEmail author,
• Huamin Henry Li,
• Timothy J. Craig,
• Michael E. Manning,
• John-Philip Lawo,
• Thomas Machnig,
• Girishanthy Krishnarajah and
• Moshe Fridman

Allergy, Asthma & Clinical Immunology201915:13

Abstract

Introduction

For prophylaxis of hereditary angioedema (HAE) attacks, replacement therapy with human C1-inhibitor (C1-INH) treatment is approved and available as intravenous [C1-INH(IV)] (Cinryze®) and subcutaneous [C1-INH(SC)] HAEGARDA®preparations. In the absence of a head-to-head comparative study of the two treatment modalities, an indirect comparison of data from 2 independent but similar clinical trials was undertaken.

• Meeting abstracts
• Open Access

Proceedings of the Canadian Society of Allergy and Clinical Immunology Annual Scientific Meeting 2018

Allergy, Asthma & Clinical Immunology201915 (Suppl 1) :10

1. Allergic Rhinitis/Asthma
2. Immunology
3. FOOD ALLERGY/ANAPHYLAXIS
4. OTHER ALLERGY/IMMUNOLOGY
5. CASE REPORT
6. ALLIED HEALTH
7. Declarations

1. 
   

World Allergy Organization Journal New articles available on ScienceDirect

World Allergy Organization Journal

New articles available on ScienceDirect

World Allergy Organization Journal Volume 12, Issue 1, Pages , 2019 Under-diagnosis of atopic dermatitis in Puerto Rican children Page 100003 Available Online 2019-01-26 Ge Yang, Yueh-Ying Han, Erick Forno, Edna Acosta-Pérez, Angel Colón-Semidey, María Alvarez, Glorisa Canino, Wei Chen, Juan C. Celedón Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria Page 100009 Available Online 2019-01-26 Emek Kocatürk, Utkan Kızıltaç, Pelin Can, Rabia Öztaş Kara, Teoman Erdem, Kübra Kızıltaç, Nagihan Sahillioğlu, Aslı Gelincik, Marcus Maurer, Karsten Weller

Electronic Clinical Decision Support System for allergic rhinitis management: MASK e‐CDSS

ORIGINAL ARTICLE 

 

Free Access

Anne‐Lise Courbis 

 

Ruth Brigid Murray 

 

Sylvie Arnavielhe 

 

Davide Caimmi 

 

Anna Bedbrook 

 

Michiel Van Eerd 

 

Govert De Vries 

 

Gerard Dray 

 

Ioana Agache 

 

Mario Morais‐Almeida 

… See all authors 

https://doi.org/10.1111/cea.13230

 

Cited by: 3

Summary

Background

Allergic rhinitis (AR) management has changed in recent years following the switch from the concept of disease severity to the concept of disease control, publication of the AR clinical decision support system (CDSS) and development of mobile health (m‐health) tools for patients (eg Allergy Diary). The Allergy Diary Companion app for healthcare providers is currently being developed and will be launched in 2018.